Cargando…
Zinc-Containing Metalloenzymes: Inhibition by Metal-Based Anticancer Agents
DNA is considered to be the primary target of platinum-based anticancer drugs which have gained great success in clinics, but DNA-targeted anticancer drugs cause serious side-effects and easily acquired drug resistance. This has stimulated the search for novel therapeutic targets. In the past few ye...
Autores principales: | Ye, Ruirong, Tan, Caiping, Chen, Bichun, Li, Rongtao, Mao, Zongwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248183/ https://www.ncbi.nlm.nih.gov/pubmed/32509730 http://dx.doi.org/10.3389/fchem.2020.00402 |
Ejemplares similares
-
Salicylate metal-binding isosteres as fragments for metalloenzyme inhibition
por: Jackl, Moritz K., et al.
Publicado: (2022) -
Designing Hydrolytic Zinc Metalloenzymes
por: Zastrow, Melissa L., et al.
Publicado: (2014) -
Computational Understanding of the Selectivities in Metalloenzymes
por: Wei, Wen-Jie, et al.
Publicado: (2018) -
Novel artificial metalloenzymes by in vivo incorporation of metal-binding unnatural amino acids
por: Drienovská, Ivana, et al.
Publicado: (2015) -
Biocatalyst–artificial metalloenzyme cascade based on alcohol dehydrogenase
por: Morra, Simone, et al.
Publicado: (2018)